Heart muscle cells derived from stem cells show remarkable adaptability to their environment during and after spaceflight, according to a study publishing November 7 in the journal Stem Cell Reports. The researchers examined cell-level cardiac function and gene expression in human heart cells cultured aboard the International Space Station for 5.5 weeks
Treatment with a cell therapy candidate called dystrophin expressing chimeras (DECs) increased dystrophin levels in heart muscle and improved cardiac function in mice with Duchenne muscular dystrophy (DMD), a study has found. This cell therapy, by Dystrogen Therapeutics, will be tested in a clinical trial involving DMD patients, with first results expected by the end of 2020, the company announced.
The American Academy of Stem Cell Physicians hosted the panel on Nov. 2 to discuss safety standards for Physicians who practice stem cell medicine
TACOMA, Wash. Seth Ack of Salt Lake City, Utah, and Samantha Webb of Lafayette, Colo., have been named University of Puget Sound Lillis Scholars.
Stem cell therapy, which All Blacks prop Owen Franks used to help fix a damaged shoulder, is raising hopes of a whole range of medical breakthroughs. But there's a way to go before the medical establishment is convinced.
For more than 15 years, Doctor Eric Bouhassira and his team have been researching stem cells at Albert Einstein College of Medicine.They say their mission is to use stem cells to create new red blood cells. According to Dr.
Stem cell research is becoming more of a taboo topic as many people of the United States move into a seemingly more anti-abortion stance. Stem cells come from a fetus that is between three to five days old (the clump of cells is called a blastocyst at this point) and can be used to reverse the effects of chemotherapy, and help repair damaged muscle.
Michael J.
This article, written byKatharine Sedivy-Haley, University of British Columbia, originally appeared on The Conversation and is republished here with permission: When I was applying to graduate school in 2012, it felt like stem cells were about to revolutionize medicine.
Salk Institute researchers have used of a state-of-the-art technology known as single-nucleus (sn) assay for transposase-accessible chromatin (ATAC) sequencing (snATAC-seq) to profile how specific types of mammary cells differentiate during development.
Recent Comments